Aleglitazar

This MedLibrary.org supplementary page on Aleglitazar is provided directly from the open source Wikipedia as a service to our readers. Please see the note below on authorship of this content, as well as the Wikipedia usage guidelines. To search for other content from our encyclopedia supplement, please use the form below:

Related Sponsors

BM Pharmacy Generic pharmaceuticals at unbeatable prices. Insomnia, men's health, hair health, pain control. bmpharmacy.com
Online Pharmacy Carisoprodol, tadalafil, sildenafil, vardenafil and more... xlpharmacy.com
MedBasket.com Discreet. Inexpensive. Fast shipping. Great selection. What more can we say? medbasket.com
Frugalmed 2000 reasons to shop with us first. frugalmed.com
Ads by Tiva

Aleglitazar
IUPAC name (2S)-2-methoxy-3-[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]-

7-benzothiophenyl]propanoic acid
Other names Ro-0728804, R-1439
Identifiers
CAS number 475479-34-6
PubChem 10274777
SMILES
 
Properties
Molecular formula C24H23NO5S
Molar mass 437.50812
Except where noted otherwise, data are given for
materials in their standard state
(at 25 °C, 100 kPa)
Infobox references

Aleglitazar is a peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ, which is being developed by Hoffmann–La Roche for the treatment of type II diabetes.1 It is currently in phase II clinical trials.2

References

  1. ^ "Statement on a nonproprietary name adopted by the USAN Council: Aleglitazar". United States Adopted Names. American Medical Association. Retrieved on 2008-08-17.
  2. ^ ClinicalTrials.gov. "A Study of Aleglitazar in Patients With Type 2 Diabetes". United States National Institutes of Health. Retrieved on 2008-03-19.
Tablets  This pharmacology-related article is a stub. You can help Wikipedia by expanding it.
v • d • e
Oral antidiabetic drugs and Insulin analogs (A10)
Insulin sensitizers
Secretagogues
GLP-1 analog
Alpha-glucosidase inhibitors
Amylin analog
Experimental
Aleglitazar† · Muraglitazar§ · Tesaglitazar§
SGLT2 inhibitor
Insulin analogs
†Undergoing clinical trials. ‡ Withdrawn from market. §Development halted.

Wikipedia content modification information:

  • This page was last modified on 3 September 2008, at 16:06.

Wikipedia Authorship and Review

Wikipedia content provided here is not reviewed directly by MedLibrary.org. Wikipedia content is authored by an open community of volunteers and is not produced by or in any way affiliated with MedLibrary.org.

Wikipedia Usage Guidelines

This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article on "Aleglitazar".

The URL for this specific entry is:

All Wikipedia text is available under the terms of the GNU Free Documentation License. (See Copyrights for details). Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc.